Cationic Liposomes in Different Structural Levels for Gene Delivery by Yinan Zhao et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
13 
Cationic Liposomes in Different  
Structural Levels for Gene Delivery 
Yinan Zhao, Defu Zhi and Shubiao Zhang 
SEAC-ME Key Laboratory of Biochemical Engineering  
College of Life Science, Dalian Nationalities University 
China 
1. Introduction 
Over the last few decades, as a promising strategy for the treatment of many refractory 
diseases, such as inherited diseases (Martin-Rendon & Blake, 2003) and acquired immuno-
deficiency syndrome (AIDS) (Fanning et al., 2003), gene therapy, the objective to allow a 
gene to express the protein coded in the target cells and consequently to treat disease by the 
protein secreted from cells transfected, has become an invaluable experimental tool to study 
gene function and its regulation (El-Aneed, 2004). The success of gene therapy critically 
depends on suitable transfection vectors, which have the high efficiency transfer of genes to 
target cells as well as a favorable safety profile. Broadly, these vectors are mainly classified 
into two categories: viral and non-viral (Liu & Huang, 2002). Currently, viral vectors based 
on many different viruses such as adenovirus and retrovirus have achieved some success 
particularly in cancer gene therapy (Williams et al., 2010), and their performance and 
pathogenicity have been evaluated in animal models. However, several issues including 
difficulty in production, limited opportunity for repeated administrations due to acute 
inflammatory response, and delayed humeral or cellular immune responses need to be 
addressed, so that their clinical potential can be fully realized (Love et al., 2010). Thus it is 
necessary to develop more efficient and flexible security system in the category of vectors 
for gene delivery. Synthetic non-viral vectors are potential alternatives to viral vectors, and 
may help to overcome some of these problems (Zhang et al., 2010). Among these, cationic 
compounds (mainly including cationic lipids and cationic polymers) are believed to cause 
less safety problems due to their relative simplicity, and have been the most extensively 
studied.  
Since the first description of successful in vitro transfection with cationic lipid by Felgner et 
al. in 1987 (Felgner et al., 1987), numerous cationic lipids have been synthesised and used for 
delivery of nucleic acids into cells during the last 20 years. Cationic liposomes are composed 
of lipid constituents, and have improved the gene delivery efficacy owing to their typical 
bilayer structure. Some helper lipids such as dioleylphosphatidyl choline (DOPC) or 
dioleylphosphatidyl ethanolamine (DOPE), typically neutrally lipids (Zuhorn et al., 2005),  
are often employed with cationic lipids, and play very important role during the formation 
of lipoplexes by combining cationic liposomes and genes, as they could determine the 
morphologies of lipoplexes. 
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Cationic polymer, which condenses DNA by ionic interaction (at physiological pH), form a 
particulate complex, polyplex, capable of gene transfer into the targeted cells (El-Aneed, 
2004). They can condense the negatively charged DNA to a relatively small size and reduce 
its susceptibility to nucleases so that they may be favorable for improving transfection 
efficacy. The introduction of polycations (such as poly-L-lysine and protamine) in cationic 
liposomes, as co-polymer may provide a synergistic effect on the transfection efficiency and 
a promising solution to the problem frustrating us (Gao & Huang, 1996; Li & Huang, 1997).  
In this chapter, we review the effect of cationic liposomes in different structural levels for 
gene delivery, and help furthering the understanding of the mechanism governing the 
formation and behaviour of cationic liposomes in gene delivery. The first level for studying 
on the structure–activity relationship of cationic lipids is the synthesis of new vectors, as 
well as attempts to improve transfection efficiencies and decrease cytotoxicity, through 
hydrophilic, hydrophobic and linker domain modifications. The second one is the study on 
morphologies of lipoplexes through the effects of helper lipids and particle sizes. The last 
one is the hybridized utilization of non-viral vectors including the complexes of cationic 
lipsomes and polymers, conjugates of lipids and peptides and of targeting moieties and 
lipids. 
2. Chemical structure of cationic compounds 
To understand the relationship between chemical structure and gene delivery, a large series 
of cationic lipids have been developed. In general, a cationic lipid used for gene therapy is 
constituted of three basic domains: a hydrophilic cationic headgroup, a hydrophobic 
domain, and a linker bond which joins the hydrophilic and hydrophobic regions (Fig. 1.) 
(Gao & Hui, 2001). The chemical structure of cationic lipids determines the physical 
parameters of the liposome and is an essential factor in both transfection activity and 
cytotoxicity levels. The effect of chemical structure modifications on gene delivery is 
discussed in detail through analyzing the large amount of literatures and exemplified 
thereinafter. 
2.1 Headgroup domain 
Since the first description of successful in vitro transfection with cationic lipid—DOTMA 
(Fig. 1.) by Felgner et al. in 1987 (Felgner et al., 1987), progress has been made in the design 
and analysis of each domain. The effect of transfection efficiency and cytotoxicity is 
associated with the cationic nature of the vectors, which is mainly determined by the 
structure of its hydrophilic headgroup. In general, the different types of headgroups fall  
into the following categories: primary, secondary, tertiary amines or quaternary ammonium 
salts (of which polyamines have often seen the most success) and guanidinium, amidine, 
as well as heterocyclic ring (Heyes et al., 2002). In addition, other charged groups that have 
been shown capable of binding plasmids have since been employed. For example, Floch  
et al. (Floch et al., 2000) showed that cationic lipids (Fig. 2.) characterized by a cationic 
charge carried by a phosphorus or arsenic atom instead of a nitrogen atom, led to an 
increased transfection efficiency (up to 7 times according to the cell lines tested) and 
reduced toxicity. 
In hydrophilic headgroup, tertiary amine or quaternary ammonium groups are the most 
frequently used in many of the established cationic lipids (Felgner et al., 1987; Gao & 
Huang, 1991; Leventis & Silvius, 1990). A typical example that modified to the chemical 
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structure of headgroup was described by Felgner et al. (Felgner et al., 1994). They 
synthesized a series of 2,3-dialkyloxy quaternary ammonium compounds containing a 
hydroxyl moiety (Fig. 3.), which were more efficient in transfection compared with DOTMA 
that lacks a hydroxyl group on the quaternary amine. In our previous work, we also 
synthesized a series of cationic lipids containing a hydroxyl moiety on the quaternary amine 
for liposome-mediated gene delivery (Fig. 4.). Several cationic liposomes with relatively 
higher transfection efficiency were selected after in vitro transfection studies of the prepared 
cationic liposomes, whose biological performance was superior or parallel to that of the 
commercial transfection agents, Lipofectamine2000 and DOTAP. It is suggested that the 
headgroup hydration can be decreased by the incorporation of a hydroxyalkyl chain capable 
of hydrogen bonding to neighbouring headgroups while it improves the compaction of 
DNA by several mechanisms, for example, DNA can form hydrogen bonds with the lipid, 
and the hydroxyl group can enhance the membrane hydration. Accordingly, several groups 
have synthesised cationic lipids that varied the chain length of the hydroxyalkyl moiety, 
while keeping the remaining structure unchanged, and observed that the activity of lipid 
increased with the decrease in the hydroxyalkyl chain length. It shows that a decrease in the 
number of carbon atoms in the hydroxyalkyl chain, providing more rigidity to the terminal 
hydroxyl group, are very efficient in compacting DNA, which is responsible for the more 
observed transfection activity ( Felgner et al., 1994; Bennett et al.,1997). 
 
 
Fig. 1. Representative structure of the cationic lipid DOTMA. Examples of cationic lipid 
structural components: hydrophilic headgroup, linker bond, and hydrophobic domain. 
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Fig. 2. Alternative cations in the lipid headgroup. 
 
 
Fig. 3. Double-chain cationic lipids containing a hydroxyl moiety on the quaternary amine. 
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Fig. 4. Transfection comparisons of lipids synthesized and commercial reagents. 
A number of cationic lipids that spread the positive charge of the cationic head by 
delocalizing it into a heterocyclic ring have been designed in an attempt to improve 
transfection efficacy and to lower toxicity. Heterocyclic cationic lipids with morpholine or 
piperazine polar heads conjugated to cholesterol directly or via a spacer (Fig. 5.) have 
been reported to compare favourably with linear polyamine head groups with similar or 
greater number of charges (Gao & Hui, 2001). And then, the use of imidazole or pyridine 
rings have been also reported to display higher transfection efficiency and reduced 
cytotoxicity when compared with classical transfection systems (Ilies et al., 2003; 
Medvedeva et al., 2009). 
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Fig. 5. Heterocyclic cationic lipids with morpholine or piperazine polar heads. 
Guanidine and its salts are important intermediates for organic synthesis and medicine; they 
have also been proposed for making cationic lipids for gene delivery. Yingyongnarongkul et 
al. (Yingyongnarongkul et al., 2004) studied a library of aminoglycerol–diamine conjugate-
based cationic lipids with urea linkage between varying length of diamines and 
hydrophobic chains, and found two compounds with bis-guanidinium and one tail had 
transfection activity superior to that of the commercial lipid transfection reagent effective 
and merit further investigation. In addition, several cationic lipids containing guanidine 
(Floch et al., 2000), amidine (Lensink et al., 2009), or cyclic guanidine (Frederic at al., 2000) in 
the head group have been studied.  
As a way to not only bind DNA but to compact DNA, polyvalent cationic lipids known as 
lipopolyamines and lipospermine were synthesized, e.g., DOSPA, DOGS (Behr et al., 
1989), are claimed to be more efficient than single-charged lipids such as DOTMA, 
DOTAP, DC-Chol, DMRIE (Ferrari et al., 1998). The choice of headgroup may depend on 
the desired and specific function of the cationic lipid, but for gene transfection it is 
essential that the headgroups of cationic lipid interact strongly with the minor groove of 
DNA via its multivalent headgroup, and has the ability to efficiently condense DNA. In 
addition, a few parameters, such as the shape (linear, T-shaped, globular, branched) and 
the length of the multivalent headgroup, and the distance between two consecutive 
nitrogen atoms in the polyamine, are also important in transfection efficiency and 
cytotoxicity (Byk et al., 1998; Fujiwara et al., 2000). 
In summary, the choice of cationic headgroups has expanded into the use of natural 
architectures and functional groups with recognized DNA binding modes. Multivalent 
cationic lipids are more likely to be the most efficient in compacting DNA; however, they 
are prone to formation of micelles typically contributing to increased toxicity (Pedroso de 
Lima et al., 2003). The incorporation of a heteroatomic group as the substitution of the liner 
amine headgroup, such as pyridinium and guanidine, can improve the compaction of DNA 
by the positive charge of the cationic head, and then transfection efficiency is increased and 
toxicity is decreased significantly. 
2.2 Hydrophobic domain 
The hydrophobic domains represent the non-polar hydrocarbon moieties of cationic lipids 
and are usually made of two types of hydrophobic moieties—aliphatic chains, steroid 
domain. Transfection efficiency and toxicity of cationic lipids can be affected by structural 
variations in the hydrophobic domain such as length, the specific type of chemical bonds, 
and the relative position of the hydrocarbon chains (Zhi at al., 2010). 
Cationic lipids with aliphatic chains have been very thoroughly researched. The chains are 
either linear and saturated or linear and mono-unsaturated and used in liposomal vectors 
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ranging from C5:0 to C18:1, but oleyl, lauryl, myristyl, palmityl and stearyl, have been the 
most researched ones (Niculescu-Duvaz et al., 2003). A common variation is the use of 
branched (Ferrari et al., 2002), acetylenic (Fletcher et al., 2006) chains and cis-
monounsaturated alkyl chains (Bennett at al., 1997). 
It is commonly believed that cationic lipids have one to four hydrocarbon chains. Several 
studies have also shown that incorporating aliphatic chains with different numbers can 
improve transfection efficiency potentially by promoting endosomal escape (Felgner et al., 
1987; Tang & Hughes, 1999a; Gaucheron at al., 2002; Zhi et al., 2010). Cationic lipids with 
double-chain hydrocarbons in the hydrophobic domain represent the majority of cationic 
lipids synthesized so far. Cationic lipids containing two aliphatic chains such as DOTMA 
and DOTAP, are among the most active lipids for systemic gene delivery. However, Tang et 
al. (Tang & Hughes, 1999a) demonstrated that 6-lauroxyhexyl ornithinate (LHON) with one 
tail was more efficient and of lower cytotoxicity compared to DOTAP. Generally speaking, 
for aliphatic chains, single-tailed and three-tailed cationic lipids are better known as 
surfactants because of their ability to form micelles in solution, but they are more toxic and 
less efficient than their double-tailed counterparts. Usually, cationic lipids with double-
tailed hydrocarbons are capable of forming liposomes by themselves or with a helper 
phospholipid. Therefore, most of the aliphatic chains in the cationic lipids are double-tailed. 
It is generally agreed that the length and saturation of the aliphatic chains incorporated into 
cationic lipids significantly affect their transfection efficiency. In order to gain chain length–
activity correlation, Felgner et al. (Felgner et al., 1994) studied a series of hydroxyethyl 
quaternary ammonium lipids with myristoyl (diC14:0, DMRIE), palmitoyl (diC16:0, DPRIE), 
stearoyl (diC18:0, DSRIE), and oleoyl (diC18:1, DORIE) chains. They observed that a 
comparison of vectors based solely on the lengths of the two aliphatic chains led to identify 
the order C14:0 > C18:1 > C16:0 > C18:0. Our study on double-chain cationic lipids also 
showed increasing transfection efficiency with decrease of the chain length (Liu et al., 2008). It 
was therefore proposed that cationic lipids with shorter chain length (for saturated chains) 
were generally important for acquiring high transfection efficiency, since they are responsible 
for membrane fluidity and good lipid mixing within the bilayer. Beyond that, the best chains 
in terms of benefit to transfection are frequently the unsaturated ones. The overwhelming 
majority of results showed that the unsaturated C18:1 oleyl was the optimal aliphatic chain, 
which was frequently the best choice for good transfection (Fletcher et al., 2006).  
Some new vectors were designed to covalently connect some special moieties in the 
hydrophobic chains, in order to get the relationship between hydrophobic chains and 
transfection efficiency. Jacopin et al. (Jacopin et al., 2001) synthesized a glycosylated 
analogue (Fig. 6.) of the dialkylamidoglycylcarboxyspermines, which formed stable particles 
at low charge ratio and was efficient for gene delivery. Many groups also reported a few 
other glycosylated cationic bolaamphiphiles similar to the compound (Fabio et al., 2003; 
Brunelle et al., 2009). In addition, the fluorinated part of the hydrophobic chain can also 
influence the transfection efficiency of cationic lipids in vivo and in vitro. Many varieties of 
fluorinated cationic lipids have been developed as transfecting agents, which are very 
efficient in compacting DNA and delivering genes into cells in vivo and in vitro (Gaucheron 
et al., 2001a, 2001b, 2001c, 2001d). 
In the steroid groups, cholesterol is by far the most frequently encountered and used as an 
alternative to aliphatic chains because of its rigidity, as well as its endogenous 
biodegradability and fusion activity. An example is cationic lipid ‘GL-67’ (Fig. 7.), which has 
been found to be particularly efficient for gene transfer to cultured cells and in murine lungs 
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(Lee et al., 1996). Other steroid compounds used as hydrophobic moieties for cationic lipids 
include vitamin D (Ren et al., 2000), bile acids (Randazzo et al., 2009), antibiotic (Kichler et 
al., 2005), cholestane and litocholic acid (Fujiwara et al., 2000). 
 
 
Fig. 6. Glycosylated analogue of lipopolyamines. 
 
 
Fig. 7. Chemical structure of GL-67. 
To summarise, the hydrophobic domain of cationic lipids mainly includes aliphatic chains 
and steroid domain, which determines the phase transition temperature and the fluidity of 
the bilayer, and influences the stability and toxicity of liposomes, the DNA protection from 
nucleases, and the DNA release from complex. 
2.3 Linker bond 
For lipids without a backbone, the linker bond that acts as a connector between the 
hydrophobic and cationic headgroup domains can affect the transfection efficiency, 
biodegradability and stability of cationic lipids. Linker bonds are commonly ether, ester 
(Leventis & Silvius, 1990), amide (Behr et al., 1989) or urethane (or carbamate) (Lee et al., 
1996) groups (Koynova & Tenchov, 2010), but other groups such as redox-sensitive 
disulphide (Byk et al., 1998, 2000) have also been employed (Fig. 1.). Cationic lipids with 
ether bonds such as DOTMA in the linker domain generally render better transfection 
efficiency, but they are too stable to be biodegraded thus may cause higher toxicity. 
Compared with ether bonds, although cationic lipids with ester bonds such as DOTAP are 
more biodegradable and associated with less cytotoxicity in cultured cells (Leventis & 
Silvius, 1990; Choi et al., 2001), those with ester may also decrease the stability of liposomes 
in systemic circulation. 
The chemistry of the linker has most often been of the carbamate or amide variety, both of 
which are chemically stable and biodegradable, and cationic lipids with these linkers could 
be used as efficient gene delivery carriers (Ren et al., 2001; Liu et al., 2005a, 2005b, 2008). A 
typical example of cationic lipid with carbamate linker is DC-Chol, which was the first lipid 
used in clinical trials because of its combined properties of transfection efficiency, stability, 
and low toxicity (Gao & Huang, 1995). As well known, when incorporating a carbamate 
group into the linker, it may therefore be hoped that the pH drop will act as a trigger, 
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disconnecting the hydrophobic and hydrophilic portions of the lipoplex, and thereby to 
release DNA after entering endosomes in cell because of the pH decreasing (Liu et al., 2005a, 
2008). We synthesized a series of carbamate-linked cationic lipids for liposome-mediated 
gene delivery, which proved to have good gene transfection properties (Fig. 4.).  
It is familiar to chemists that compounds comprising redox-sensitive disulphide bonds is 
stable chemically as long as no reducing agents, and it is expected that these disulphide-
linked lipids can keep stable in the circulation system while decomposing to release DNA 
after entering endosomes in cells (in a similar manner as the pH-sensitive systems) (Tang & 
Hughes, 1999b). Byk et al. (Byk et al., 1998, 2000) prepared a series of lipopolyamines that 
harbor a disulfide bridge within different positions in the backbone of the lipids as 
biosensitive function. They found that an early release of DNA during or after penetration 
into cells, probably promoted by reduction of a disulfide bridge placed between the 
polyamine and the lipid, implied a total loss of transfection efficiency. 
In addition, structural variations at the linker region such as length, the specific type of 
chemical bonds and the relative position of the hydrocarbon chains can affect the 
transfection efficiency, biodegradability and stability of cationic lipids (Fujiwara et al., 
2000). The level of hydration and toxicity of the lipid can also be determined by the length 
of the linker (Floch et al., 2000). In a word, the use of linkers incorporating functional 
groups that are cleavable on shorter time scales and under specific stimuli is however of 
emerging interest, as DNA release may here be facilitated by a triggered decomplexation 
mechanism. 
From the chemistry point of view, the structure of cationic compounds is an important 
factor for their transfection activity and toxicity. Some common conclusions can be achieved 
by comparing the different structures and their transfection activity in the same family or 
different families of lipids. The transfection efficiency is not only determined by one domain 
of cationic lipids, but also depends on the combination of them (Tang & Hughes, 1999a). In 
general, it seems when researchers design cationic compounds for gene delivery, the 
balances between the opposite factors including fluidity and rigidity, symmetry and 
asymmetry, saturation and unsaturation, linearity and branching, short chain and long 
chain, hydrophilicity and lipophilicity of compounds should be taken into serious 
consideration. 
3. Helper lipids and morphology of lipoplexes 
Neutrally charged helper lipids such as DOPE, DOPC (Fig. 8.), are often employed with 
cationic lipids in order to gain high transfection efficiency (Felgner & Ringold, 1989). When 
cationic liposomes are mixed with DNA, lipoplexes are formed with heterogeneous 
morphologies including beads on a string structure (Felgner & Ringold, 1989), spaghettis or 
meatballs structure (Sternberg et al., 1994), multilamellar structure LCα, inverted hexagonal 
phase structure HCII (Koltover et al., 1998), a map-pin structure (Sternberg et al., 1998) and a 
sliding columnar phase (O’Hern & Lubensky, 1998). Helper lipids play very important role 
during the formation of lipoplexes by combining cationic liposomes and genes, as they 
could determine the morphologies of lipoplexes. It has shown lipoplex size is very 
important for gene transfer to actively endocytosing cells (Ross & Hui, 1999), as such the 
influences on transfection efficiency: DNA ratio, types of liposomes, incubation time in 
polyanion containing media, and time of serum addition, are channeled mostly through 
their influences on lipoplex size.  
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Fig. 8. Chemical structure of DOPE and DOPC.  
3.1 DOPE 
DOPE often presents a super synergistic effect when used in cationic liposomes, because 
DOPE destabilized lipid bilayers, and it was believed to be involved in endosomal 
disruption (Litzinger & Huang, 1992), allowing the release of DNA into the cytosol (Farhood 
et al., 1995) and leading to mixed bilayers (Scarzello et al., 2005). Most studies have shown 
that lipoplexes containing the non-bilayer-phase-preferring lipid DOPE or cholesterol would 
promote HCII organization (Zuhorn et al., 2005). A transition from the LCǂ phase to the HCII 
phase could be expected by increasing weight fraction of DOPE, via controlling the 
spontaneous radius of curvature “Ro” of the lipid layers, favored by the elastic free energy 
(Safinya, 2001). Another helper lipid, cholesterol, could also promote HIIC organization as 
DOPE. It has been proved that in vivo applications cholesterol was a more effective helper 
lipid than DOPE (Lasic, 1997).  
Koltover et al. (Koltover et al., 1998) disclosed the reason in the level of phase transition 
through synchrotron small-angle X-ray scattering (SAXS) and optical microscopy to show 
the phase transition from LǂC to HIIC induced by DOPE via controlling the spontaneous 
curvature Co = 1/Ro of the lipid monolayer. It has been concluded that DOPE facilitates 
endosomal escape by forming an unstable inverted hexagonal phase at the endosomal pH 
that destabilizes both the complex and the endosomal membrane. But in a recent study  
(Leal et al., 2010), they developed CL-siRNA complexes with a novel cubic phase 
nanostructure exhibiting efficient silencing at low toxicity by using glycerol monooleate 
other than DOPE as the helper lipid. The inverse bicontinuous gyroid cubic nanostructure 
was unequivocally established from synchrotron X-ray scattering data, while fluorescence 
microscopy revealed colocalization of lipid and siRNA in complexes. 
Tubes of lipoplexes containing DOTAP/MOG, DOTAP or DOTAP/PC, and DOTAP/DOPE 
were observed in freeze-fracture electron micrographs. The tubes were extremely short and 
appeared bead-like in lipoplexes containing DOTAP/MOG, slightly longer in those 
containing DOTAP or DOTAP/PC, and extensively elongated in DOTAP/DOPE lipoplexes 
(Xu et al., 1999). The spaghetti-like structures, occurring at DNA: lipid concentrations which 
were used during transfection and their diameter came closest to the diameter of the nuclear 
pores, may be the active cationic lipoplexes (Zhdanov et al., 2002). In the study of the 
structure and morphology of DC-Chol–DOPE/DNA complexes it was found the existence 
of cluster-like aggregates made of multilamellar DNA/lipid domains coexisting with other 
multilamellar lipoplexes or, alternatively, with DNA-coated vesicles (Amenitsch et al., 2010). 
The further study showed that DC-Chol-DOPE/DNA lipoplexes preferentially used a raft 
mediated endocytosis, while DOTAP-DOPC/DNA systems were mainly internalized by not 
specific fluid phase macropinocitosys. Most efficient multicomponent lipoplexes, 
incorporating different lipid species in their lipid bilayer, can use multiple endocytic 
pathways to enter cells. Their data demonstrated that efficiency of endocytosis was 
www.intechopen.com
 
Non-Viral Gene Therapy 
 
302 
regulated by shape coupling between lipoplex and membrane lipids to suggest that such a 
shape-dependent coupling regulated efficient formation of endocytic vesicles thus 
determining the success of internalization (Marchini et al., 2010).  
Kato et al. (Kato et al., 2010) observed the effect of phase separation of the membrane by 
changing PE from DOPE to dipalmitoylethanolamine (DPPE), which corresponded to a 
change from a homogeneous single phase to two segregated phases of liquid-ordered and 
liquid-disordered states on the membrane. This study further proved that helper lipids 
could change the morphologies of lipoplexes through the mutual interaction with DNA 
based on their chemical structures. Several helper lipids such as 
dilauroylphosphatidylethanolamine (C12:0), dimiristoylphosphatidylethanolamine (C14:0), 
dipalmitoylphosphatidylethanolamine (C16:0), diphytanoylphosphatidylethanolamine 
(C16:0, branched), distearoylphosphatidylethanolamine (DSPE, C18:0) were compared with 
DOPE (C18:1) to show that the branched and unsaturated species combined with cationic 
lipids acted in physical synergism to increase transfection efficiency (Heinze et al., 2010). 
3.2 DOPC 
Ewert et al. (Ewert et al., 2004) demonstrated that σΜ, the average membrane charge density 
of the CL-vector, was a key universal parameter that governed the transfection behavior of 
LǂC complexes in cells. DOPC favors the formation of LǂC type of lipoplexes, in which, a 
system of DOPC/DOTAP-DNA lipoplex showed a strong dependence on the molar fraction 
of neutral lipid DOPC (ΦDOPC) and therefore membrane charge density σΜ. The 
transfection efficiency started low for 0.5 < ΦDOPC < 0.7 and increased dramatically to a 
similar value, at ΦDOPC = 0.2, with HIIC lipoplex achieved by the DOPE/DOTAP-DNA. In 
contrast to LǂC complexes, HIIC complexes containing DOPE exhibited no dependence on σM. 
The transfection efficiency increased exponentially with a linear increase of σΜ for the 
MVL5/DOPC/DNA lipoplex bearing LǂC (Ewert et al., 2002). And then, they found that the 
curve of transfection efficiency versus σΜ assumed a bell-shape with increasing σΜ using 
MVL type of cationic lipids (Ahmad et al., 2005). Ewert et al. (Ewert et al., 2006) also found 
that hexagonally arranged tubular lipid micelles (HIC) surrounded by DNA rods were 
formed though DOPC was used in the dendritic lipid-based cationic liposome. 
Later it has been proved that the enhanced transfection efficiency was supported by a meso-
scale computer modeling of cationic lipid lipoplexes in LǂC phase at high concentrations of 
cationic lipid (Farago et al., 2006). Recently, a study (Kedika & Srilakshmi, 2011) showed 
that DOPC was a more efficacious colipid than DOPE. The difference in the transfection 
efficiencies of lipoplexes in the presence of colipids DOPE and DOPC was explained as the 
uptake of the lipoplexes in the presence of DOPE took place mainly from the fusion of the 
lipoplexes with the plasma membrane, whereas “endocytosis” facilitated uptake in the 
presence of DOPC. Many researchers have agreed membrane charge density σΜ is a 
universal parameter governing the transfection efficiency of LCǂ lipoplexs (Ewert et al., 
2005a, 2005b; Lin, 2003). But for the question, which morphology among LǂC governed main 
by DOPC and HIIC governed mainly by DOPE is favored in terms of transfection efficiency, 
we still need to carry out more research.  
3.3 Lipoplex sizes 
Another parameter of morphologies affecting transfection efficiency is lipoplex sizes, for the 
important role of lipoplex sizes in determining the nature of the entry pathway by 
endocytosis (Wasungu & Hoekstra, 2006). Though it is difficult to unify the size effect of 
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lipoplexs on the transfection activity so far, most transfection complexes fall within  
an average size range of 100–300nm. The lipoplex particles can be categorized as  
small (≤100nm), medium (100–200nm), large (200–1000nm) or giant (≥1000nm). (Donkuru  
et al., 2010). 
Some times large lipoplexes sizes could be more efficient to transfer genes because large 
particles lead to maximum contact with cells (Kennedy et al., 2000), the formation of large 
intracellular vesicles which are more easily disrupted, thus releasing DNA into the 
cytoplasm (Escriou et al., 1998), phagocytic activity accompanied by endosomal escape 
(Xu et al., 1999) and faster sedimentation and better cellular trafficking (Lee et al., 2003). 
At the same time, some reports supported that particles with smaller size would gain high 
transfection efficiency (Pitard et al., 1997; Kneuer et al., 2006). The requirement for 
efficient transfection may be different in vivo and in vitro. Compared with in vitro delivery, 
small particles tend to have high transfection efficiency in vivo because of the ability of 
small particles to traverse narrow capillary networks. Large particles typically have low 
in vivo transfection efficiencies, while 200-400nm is the optimal size for lipoplexes in vitro 
(Zhdanov et al., 2002; Kennedy et al., 2000). Measurement of the endosomal uptake of 
fluorescent dextran beads of various sizes clarified that particles smaller than 200 nm 
were predominantly taken up by means of clathrin mediated endocytosis; with increasing 
the size, a shift to another mechanism occurred, so that particles larger than 500 nm were 
taken up predominantly by caveolae mediated pathways (Rejman et al., 2004). 
Carriere et al. (Carriere et al., 2002) have proved that lipofection inhibition by serum was 
largely due to the serum inhibition of lipoplex size growth, and may be overcome by using 
large, stable lipoplexes. Lipoplexes of over 700 nm mean diameter induced efficient 
transfection in the presence or absence of serum (Turek et al., 2000), but lipoplexes of less 
than 250 nm in size showed efficient transfection only in the absence of serum. It was 
reported that the particle sizes may be one of the factors that were contributed to serum 
resistance of EDL (ethanol-dried lipid-DNA) lipoplexes, and the large cationic lipoplexes 
may delay the dissociation of DNA with lipid, thereby enhancing DNA transfection 
efficiency (Lian & Ho, 2003). 
Although a general rule is not obtained until now, there is no doubt that high transfection 
would be gained from large lipoplexes when endocytosis is dominant, because large 
particles facilitate membrane contact and fusion. When cells are not actively endocytosing, 
either small particles may have high transfection efficiency, or lipoplex sizes don’t correlate 
with lipofection efficiency. The possibility of a final agreement on the lipoplexes size effect 
may be very small, as the other conditions of every transfection case could be different. The 
controllable assembly of lipoplexes may provide a solution to this problem. 
4. Hybrid vectors based on cationic lipids 
The hybridized utilization of non-viral vectors also provides an alternative solution to the 
delivery of genes. We could hybridize cationic lipsomes and polymers; introduce peptides 
and targeting moieties into lipids for approaching the requirements of gene therapy (Zhang 
et al., 2010).  
4.1 Hybrids of cationic liposomes and polymers 
Cationic polymers could combine with DNA to form a particulate complex, polyplex, 
capable of gene transfer into the targeted cells (El-Aneed, 2004), because most of them are 
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completely soluble in water. Therefore, they have the obvious advantage of compressing 
DNA molecules to a relatively small size (Gershon et al., 1993; Ruponen et al., 1999). But 
they do not contain a hydrophobic moiety (Elouahabi & Ruysschaert, 2005), this may hinder 
the transfection efficiency and cause cytotoxicity to some degree.  
Liposome-mediated gene transfer could be improved by natural polycations such as 
protamine sulfate (PS), poly(L-lysine) (PLL), and spermine  (Li & Huang, 1997; Cheng et al., 
2009). The addition of poly(L-lysine) and protamine dramatically reduced the particle size of 
the complex formed between DNA and cationic liposomes and rendered DNA resistant to 
the nucleases (Gao & Huang, 1996). These polycations could form a complex with DNA and 
condense DNA from extended conformation to highly compact structure into 30-100 nm in 
size. A type of hybrid vectors were developed by Huang et al. (Gao & Huang, 1996; Lee & 
Huang, 1996) in which poly(lysine)-condensed DNA was entrapped into folate-targeted 
cationic liposomes (LPD). They found LPD vectors to be more efficient and less cytotoxic 
compared to conventional cationic liposomal vectors. Later, they modified LPDs through 
different cationic liposomes wherein LPDs were used to deliver antisense 
oligodeoxynucleotide and siRNA (Li & Huang, 2006; Chen et al., 2009; Gao & Huang, 2009).  
As a cationic polymer, PEI is commonly used for the delivery of genes. The hybrid usage 
with cationic liposomes provides a promising way to the field of gene transfer. In a study, 
the combination of PEI and DOTAP-Chol caused more than 10-fold increase in the 
transfection efficiency and less toxicity in many cells compared with using polymer or 
liposome alone(Lee et al., 2003). Nearly at the same time, PEI2K-DNA-Dosper complexes 
showed much more cellular uptake of DNA than PEI2K-DNA complexes and two times 
higher transfection than Dosper-DNA complexes. It has been hypothesized that Dosper 
improved the cellular uptake of PEI2K-DNA complexes and PEI2K improved a transfer of 
the complexes from lysosomes to nucleus (Lampela et al., 2003).  
In recent years, chitosan-based carriers have become one of the non-viral vectors that have 
gained increasing interest as a safer and cost-effective delivery system for gene materials, as 
they have beneficial qualities such as low toxicity, low immunogenicity, excellent 
biocompatibility as well as a high positive charge density (Zhang et al., 2007; Mao et al., 
2010). Katas et al. (Katas & Alpar, 2006) may be the first group to investigate the use of 
chitosan to deliver siRNA in vitro. Two types of cell lines, CHO K1 and HEK 293 were used 
to reveal that preparation method of siRNA association to the chitosan played an important 
role on the silencing effect. Chitosan-TPP nanoparticles with entrapped siRNA were shown 
to be better vectors as siRNA delivery vehicles compared to chitosan-siRNA complexes 
possibly due to their high binding capacity and loading efficiency. We have combined 
chitosans and cationic liposomes to form a ternary lipopolyplex which could facilitate the 
delivery of genes into cells more efficiently than the utilization of a lipoplex or a polyplex 
alone (Fig. 9.). The confocal microscopy method proved that exogenous DNA molecules 
entered the nucleus through the nuclear membrane other than via the NPC. The results 
explored novel ways based on the hybrid vectors to enhance the pDNA delivery with 
chitosans and with further suitable intracellular mechanism, allowing the development of 
nonviral gene delivery and may provide the most exciting solution for hybrid biomaterials 
design used for beneficial candidates for gene therapy. 
4.2 Conjugates of peptides and lipids 
One of the most challenge things for gene delivery by cationic liposome method is the 
toxicity of cationic lipids originated in the cationic nature. The replacement of cationic head  
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Fig. 9. The role of chitosans on transfection efficiency of cationic liposomes. (A in Hela cells, 
A1: lipoplex, A2: polyplex, A3: lipopolyplex 1, A4: lipopolyplex 2; B in Hep2 cells, B1: 
lipoplex, B2: lipopolyplex 1, B3: lipopolyplex 2, B4: lipopolyplex 3) 
groups has been a major trend with other more biocompatible groups, such as peptides, in 
recent years, as the cationic lipids with quaternary ammonium head groups can become 
cytotoxic by interacting with critical enzymes such as PKC (Bottega & Epand, 1992). The 
commonly used headgroups are peptides consisting of amino acids, such as lysine, arginine, 
histine, ornigine and tryptophan. Therefore, the conjugates of peptides and lipids are much 
less toxic, whilst keeping the same transfection efficiency (Behr et al., 1989; Ahn et al., 2004).  
The first polypeptide cationic liposome prepared by a polycondensation reaction was 
described by Folda et al. (Folda et al., 1982). A subset of lipitoids with a repeated side chain 
trimer motif conjugated with dimyristoyl phosphatidyl-ethanolamine (DMPE) mediated 
DNA were also found to transfer cells with high efficiency (Huang et al., 1998). A compound 
which contained cholesterol and a dipeptide consisting of glycine and sterically protected 
arginine has been proved to be suitable for in vitro transfection in the presence of 10% sera 
more efficiently than other cholesterol derivatives (Sochanik et al., 2000). Peptide-based 
gemini surfactants GS could lead to an increase in levels of gene expression in vitro 
compared to well-established non-viral reagents (McGregor et al., 2001). 
Obata et al. (Obata et al., 2008) have proved that the lysine- or arginine-type lipids exhibited 
higher gene expression efficiencies than that of Lipofectamine2000, with COS-7 cells. A 
series of new lipophilic peptides possessing a cationic tripeptide headgroup were effective 
non-viral vectors for gene delivery. Then, they also synthesized a series of cationic amino 
acid-based lipids having a spacer between the cationic head group and hydrophobic 
moieties and examined the influence of the spacer on a liposome gene delivery system. 
(Obata et al., 2009). At present, they are investigating the ability of cationic liposomes 
composed of 1,5-dihexadecyl N-arginyl-L-glutamate (Arg-Glu2C16) to carry nucleic acids 
into neuronal cells. Arg-Glu2C16, as a model cationic amino acid-based lipid, had a high 
capability as a gene carrier, even for neuronal transfection (Obata et al., 2010). Coles et al. 
(Coles et al., 2010) has synthesized positively charged peptide-based carriers which could 
interact with DNA improved by performing isothermal titration calorimetry and particle 
size and zeta potential experiments. The particle sizes of the carrier/DNA complexes varied 
over the different charge ratios from 200-800nm. The utilization of lipophilic carriers is a 
promising approach to improve the bioavailability of gene delivery. 
Some peptide head groups could endow additional functions to the lipids, such as 
membrane-disturbing ability. In a hybrid molecule, the covalent coupling of an amphipathic 
and membrane-disturbing peptide to a lipid moiety might create a stable and efficient 
www.intechopen.com
 
Non-Viral Gene Therapy 
 
306 
peptide-based gene transfer system. The luciferase activity induced by the 
dioleoylmelittin/DNA complex was 5-500-fold higher than that induced by a cationic 
lipid/DNA complex, depending on the cationic lipid and the cell-line (Legendre et al., 1997). 
Later, a membrane-disrupting peptide derived from the influenza virus was covalently 
linked to different polymethacrylates using N-succinimidyl 3-(2-pyridyldithio)propionate 
(SPDP) as a coupling agent to increase the transfection efficiency of polyplexes based on 
these polymers. In vitro transfection and toxicity were tested in COS-7 cells, and these 
experiments showed that the polyplexes with grafted peptides had a substantially higher 
transfection activity than the control polyplexes, while the toxicity remained unchanged  
(Funhoff et al., 2005).  
4.3 Conjugates of targeting moieties and lipids 
For a number of gene therapy applications, targeted gene delivery systems have attracted 
great attention due to their potential in directing the therapeutic genes to the target cells, 
and it may help minimize adverse effects such as cytotoxicity or immune reactions, as well 
as maximizing the efficacy of the therapeutic response. The targeted delivery of the 
lipoplexes may be achieved through the addition of targeting moieties (e.g., ligands) into 
liposomes by direct formulation, with no covalent bond to any lipid (Seol et al., 2000); 
conjugated to helper lipid (Dauty et al., 2002), or connected directly to the cationic lipids 
(Kawakami et al., 2000a; Gaucheron et al., 2001c). For targeted lipoplexes, modified with a 
targeting moiety such as folate (Dauty et al., 2002), galactose(Kawakami et al., 2000a; 
Gaucheron et al., 2001c), mannose (Kawakami et al., 2000b), antibodies (Duan et al., 2008) 
and transferrin (Seol et al., 2000; Sakaguchi et al., 2008), the uptake can be receptor mediated 
and enhanced (Zhang et al., 2010). 
Targeting of the folate receptor (FR) had received much attention in recent years, since the 
folate receptor is a tumor marker over expressed in large numbers of cancer cells, 
including cancers of the ovary, kidney, uterus, testis, brain, colon, and in addition, folic 
acid is a relatively small molecule (MW 441 Da), therefore, it has the advantages of being 
stable and nonimmunogenic compared to monoclonal antibodies (Kane et al., 1986), and 
still having a relatively high receptor affinity. In a study, the folate moiety was attached to 
a lipid membrane anchor via a cysteinyl-PEG3400 spacer, which greatly increased specific 
cellular uptake to FR overexpressing cancer cells in comparison with unmodified cationic 
liposome and can significantly improve the transfection efficiency of a cationic liposomal 
formulation (Reddy et al., 2002). Recently, Yoshizawa et al. (Yoshizawa et al., 2008) 
developed a folate-linked nanoparticle (NP-F), which was composed of cholesteryl-3ǃ-
carboxyamidoethylene-N-hydroxyethylamine, Tween 80 and folate-poly(ethylene glycol)-
distearoyl-phosphatidylethanolamine conjugate (f-PEG2000-DSPE), and was delivered 
synthetic siRNA with high transfection efficiency and selectivity into nasopharyngeal 
tumor KB cells. 
The asialoglycoprotein receptor (ASPGR), present at the surface of hepatocytes, could 
recognize and bind to ǃ-D-galactoside terminated glycoproteins for the targeting of cationic 
vector-based gene delivery systems (Ashwell & Harford, 1982). Kawakami et al. (Kawakami 
et al., 1998) have studied liposomal with asialoglycoprotein receptor gene carrier systems for 
gene delivery to hepatocytes, which was a novel galactosylated cholesterol derivatives, 
cholesten-5-yloxy-N-(4-((1-imino-2-ǃ-D-thiogalactosylethyl)amino)alkyl) formamide. In 
human hepatoma cells (HepG2), the liposomes containing this galactolipid showed higher 
transfection activities than DC-Chol liposomes based on a receptor-mediated mechanism. 
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Later, they used galactosylated cationic liposomes to target liver cell asialoglycoprotein 
receptors in vivo (Kawakami et al., 2000a). Many groups also reported a few other 
glycosylated cationic bolaamphiphiles similar to the compound (Letrou-Bonneval et al., 
2008). Brunelle et al. (Brunelle et al., 2009) synthesized a new series of dissymmetric 
hemifluorocarbon bolaamphiphiles (Fig. 10.), and the dissymmetric functionalization of 
diiodoperfluorooctane led to bolaamphiphile molecules composed of a partially 
fluorocarbon core end-capped with a glycoside and an ammonium salt. They found that the 
incorporation of two fluorinated segments in the molecular structure of the bolaamphiphiles 
is detrimental for an efficient DNA condensation. 
 
 
 
 
 
Fig. 10. A set of dissymmetric hemifluorocarbon bolaamphiphiles. 
The mannose receptor (MR) is found on the surface of macrophages and dendritic cells can 
recognize complex carbohydrates that are located on glycoproteins that are a part of many 
different biological processes, and bind terminal mannoses found on vector. Kawakami et al. 
(Kawakami et al., 2000b) have developed a novel mannosylated cholesterol derivative, Man-
C4-Chol, consisting of modified cationic liposomes with mannose moieties for NPC-
selective gene delivery via mannose receptors on NPC. The mannosylated cationic 
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liposomes can deliver pDNA to liver nonparenchymal cells (Kawakami et al., 2000b) and 
splenic DCs and improve immune activation in DNA vaccines (Hattori et al., 2004).  
Since theirs early use for the targeting to erythroblasts (Zhang et al., 2010), targeting proteins 
such as antibodies or transferrin have become one of the most widely used ligands for 
targeting of synthetic vectors, and been used in conjunction with cationic lipoplexes (Rao, 
2010) to mediate uptake of plasmid DNA and antisense oligonucleotides. Another important 
class of cell proteins with promise for targeted gene delivery is growth factor receptor, 
which is a most commonly single pass transmembrane protein with an extracellular ligand 
binding domain and an intracellular region with enzymatic activity, usually a tyrosine 
kinase domain, which transmits a growth factor signal from the cell's environment to its 
interior. It has been used to target polylysine complexes (Cristiano & Roth, 1996), liposomes 
(Kikuchi, 1996), PEI polyplexes (Cristiano & Roth, 1996), and adenovirus-derived peptides 
(Medina-Kauwe et al., 2001) to receptor-positive cells. 
Targeting provides a generic strategy to improve the specificity of a pharmaceutical 
formulation independently of the specificity of the drug or gene itself, primarily through a 
modulation of the carriers’ biodistribution, so that a dose differential is created between 
healthy and diseased tissue.  
5. Conclusion 
Cationic lipisomes-mediated gene transfer has shown to be a safe and effective way to 
transfer genes for gene therapy, and will gain clinical application in the near future. Some 
traditional cationic lipids have been used in gene transfer for a long time; many of them 
have trademarks such as lipofectin, lipofectamine and transfectam. These cationic lipids, 
however, may not be enough for the application in clinical trials; on the other hand, they 
have some shortcomings for a special application field. Therefore, many novel cationic 
lipids in chemical structure nature have been researching to meet the requirements with 
respect to gene therapy. Besides the lipid structure the next level should be the formulations 
of cationic liposomes, as in order to increase transfection efficiency and to decrease 
cytotoxicity other ingredients such as heper lipids could be chosen. Different formulations 
may cause various morphologies of lipoplexes formed by the combination between cationic 
liposomes and genes. It shows that the purposeful design of morphologies could increase 
transfection efficiency. The hybrid utilization of non-viral vectors based on cationic 
liposomes provides another solution to gene delivery. Much research has shown the 
promising combination between cationic lipsomes and polymers, the favorable conjugation 
between lipids and peptides and between targeting moieties and lipids. 
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